Insights

Are GLP-1s Worth the Cost for Weight Loss? A Data-Driven Look for Payers 

Learn More

Why Your PBM May Be the Most Consequential Part of Your Health Plan

Learn More

Q2 Drug Approvals and Biosimilar Changes Impacting Your Pharmacy Strategy 

Learn More

7 Key Things You Need to Know About Tariffs and Pharmaceuticals

Learn More

How the 2025 American Diabetes Association Guidelines Will Impact Your Pharmacy Benefit Strategy 

Learn More

5 Ways to Win RFP Season (Before It Even Starts)

Learn More

Weight Management Benefits: A Strategic Guide for Brokers and their Plan Sponsors

Learn More

Filter Insights:

Join our newsletter to stay up to date on market trends.

By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.

Latest Insights

Q3 2026 Drug Updates: New FDA Approvals, Generics and Biosimilars to Watch 

OnPoint-Light-Dark 2

A Navion Video Series

Welcome to On Point with Navion. In five minutes or less, we’ll break down what’s happening in pharmacy, what it means for your groups, and what to do next. No fluff, just what you need to know every month.

GET STARTED

Experience Navion in action with a savings analysis!

Our custom Rx savings analysis delivers a side by-side assessment to ensure your groups have a single source of truth to choose the PBM option that’s right for them.